Home › NASDAQ: ATXI
Biotechnology
ATXI
0.7005
Price1.52%   +0.0105
pre-market Pre-market: .7493 0.0488 +6.97%

Avenue Therapeutics (ATXI)
loading

KEY STATS

Previous Close:
$0.69
Market Cap:
$6.09M
24h Volume:
70,238
1D Range:
$0.64 - $0.7035
52W Range:
$0.539 - $16.65
Primary Exchange:

COMPANY PROFILE

NameNameAvenue Therapeutics
sectorSectorHealthcare (1499)
industryIndustryBiotechnology (867)
webWebavenuetx.com
phonePhone781 652 4500
employeeEmployee4
twitter-icon Twitter @avenuethera
chart-line-icon Latest SEC Filings
twitter-icon ATXI's Discussions on Twitter
clock2023-11-01
location1140 Avenue of the America, 9th Floor, New York, NY, United States (10036)
News Price History Option Chain Financials Insider Trading Why ATXI Down? Discussions Forecast Stock Split Dividend History

Avenue Therapeutics Stock (ATXI) Option Chain

Options are not available

About Avenue Therapeutics

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):